Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease

Mekky Mohamed A.; Abdel-Malek Mohamed O.; Osman Heba A.Abdel-Aziz Essam M.Hashim Abdel-Kader A.Hetta Helal F.Morsy Khairy H.

首页> 外文期刊>Clinics and research in hepatology and gastroenterology >Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease

【24h】

Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease

机译：

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相关主题

摘要

Background: Till now, pooled data about the safety and efficacy of different direct-acting antiviral (DAAs) regimens in different renal situations are still under evaluation.

著录项

来源
《Clinics and research in hepatology and gastroenterology 》 |2019年第1期| 82-87| 共6页
作者
Mekky Mohamed A.; Abdel-Malek Mohamed O.; Osman Heba A.Abdel-Aziz Essam M.Hashim Abdel-Kader A.Hetta Helal F.Morsy Khairy H.;
展开▼
作者单位

Assiut Univ, Fac Med, Trop Med & Gastroenterol Dept, Hepatol Div, Assiut 71515, Egypt;

South Valley Univ, Fac Med, Trop Med & Gastroenterol Dept, Hepatol Div, Qena, Egypt;

Assiut Univ, Fac Med, Dept Internal Med, Nephrol Div, Assiut, EgyptSouth Valley Univ, Fac Med, Dept Internal Med, Nephrol Div, Qena, EgyptAssiut Univ, Fac Med, Med Microbiol & Immunol Dept, Assiut, EgyptSohag Univ, Fac Med, Trop Med & Gastroenterol Dept, Hepatol Div, Sohag, Egypt;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类消化系及腹部疾病 ;
关键词
HCV; End-stage kidney disease; DAAs;

Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease

摘要

著录项

相关主题

期刊订阅